Glucosamine for the Treatment of Osteoarthritis: The Time Has Come for Higher-Dose Trials

Volume: 16, Issue: 2, Pages: 179 - 192
Published: Apr 18, 2018
Abstract
Although clinical trials with glucosamine in osteoarthritis have yielded mixed results, leading to doubts about its efficacy, the utility of glucosamine for preventing joint destruction and inflammation is well documented in rodent models of arthritis, including models of spontaneous osteoarthritis. The benefit of oral glucosamine in adjuvant arthritis is markedly dose dependent, likely reflecting a modulation of tissue levels of...
Paper Details
Title
Glucosamine for the Treatment of Osteoarthritis: The Time Has Come for Higher-Dose Trials
Published Date
Apr 18, 2018
Volume
16
Issue
2
Pages
179 - 192
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.